Bain Capital Life Sciences portfolio
20 tracked investments, 5 on the map, $1B raised across the mapped portfolio.
- Imperative CareSeries E
- JENAVALVE TECHNOLOGYSeries C
- ADARx PharmaceuticalsSeries C
- HeartflowConvertible Note
- Dicerna Pharmaceuticals
Also in the portfolio
- Nimbus Therapeutics
- Dianthus Therapeutics
- Upstream Bio
- Xilio Therapeutics
- Rivus Pharmaceuticals
- Alkeus Pharmaceuticals
- Replimune Group
- AavantiBio
- Aiolos Bio
- C4 Therapeutics
- Eyebiotech
- Savara Pharmaceuticals
- X4 Pharmaceuticals
- Pharvaris
- Atea Pharmaceuticals